ArticleJournal for immunotherapy of cancer2021

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer.

Peter J DeMaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.